ERBB2 and breast cancer: Given such findings, we hypothesized whether hsa‐miR‐29a‐5p is a BC biomarker; our findings showed that the expression of this miRNA increased in tumor samples (especially in advanced TNM stages, videlicet stage III) and also in HER‐2 positive cells.